Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

University of Cagliari121 enrolled

Overview

The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.

Study Type

OBSERVATIONAL

Enrollment

121

Conditions

SARS-CoV Infection Seroprevalence Covid19

Interventions

Antibodies testingDIAGNOSTIC_TEST

Serologic test for both SARS-COV-2 IgG and IgM

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient admitted to our unit who had performed SARS-COV-2 serologic test Exclusion Criteria: * age \< 18

Locations (1)

University of Cagliari

Cagliari, Italy

Outcomes

Primary Outcomes

SARS-COV-2 seroprevalence

SARS-COV-2 IgG and IgM seroprevalence between spring and fall period

Time frame: 1St September - 10Th December 2020

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.